Search
Tractament antiviral de l'hepatitis C crònica a l'any 2019, 2020 i 2021: informe d'avaluació de resultats
(2022-02)
Minority diseases pose a major challenge to the health system, as they often have a genetic origin, can affect many organs, be serious, pose a vital threat, or be chronically debilitating. Their diagnosis is difficult, ...
Luteci (177Lu) oxodotreotida per al tractament de tumors neuroendocrins gastroenteropancreàtics positius al receptor de somatostatina, ben diferenciats, progressius i irresecables o metastàtics
(2020-07-07)
Neuroendocrine tumors (TNEs) are defined as those neoplasms with a predominantly neuroendocrine cell differentiation, which can arise in most organs, although most are of gastrointestinal or pancreatic origin (≈65%). The ...
Document informatiu dels fàrmacs d'acció lenta sobre els símptomes de l'artrosi (SYSADOA)
(2020-10-27)
Slow-acting drugs on the symptoms of osteoarthritis or SYSADOA (from the acronym in
English, SYmptomatic Slow Action Drugs for OsteoArthritis) are glucosamine (a
aminomonosaccharide, in the form of sulphate or ...
Tractament de malalties minoritàries amb medicaments d'autorització individual a l'any 2019: informe d'avaluació de resultats
(2020)
Minority diseases pose a major challenge to the health system, as they are often of genetic origin and can affect many organs, be serious, pose a threat to life, or be chronically debilitating. Their diagnosis is difficult, ...
Argumentari de les pautes per a l’harmonització del tractament farmacològic de la incontinència urinària
(2021-03-04)
The CatSalut Pharmacotherapeutic Harmonization Guidelines are a tool aimed at all healthcare professionals to establish good practices in the pharmacological management of different priority pathologies. Urinary incontinence ...
Tractament farmacològic de la malaltia d’Alzheimer: informe del Registre de Tractament Farmacològic de la Malaltia d’Alzheimer a l’any 2019
(2020)
Alzheimer’s disease (AD) is a progressive, irreversible neurodegenerative disorder that is usually slow but sustained over time. AD is the most common cause of dementia (69%). Its prevalence is 5.1% and increases exponentially ...
Tractament del CPNM metastàtic EFGR positiu amb inhibidors d’ITK en primera línia: informe d'avaluació de resultats
(2021)
Lung cancer (LC) is one of the most frequently diagnosed cancers worldwide. In Spain, the estimated incidence of new cases of LC for 2019 was 29,503 cases. LC remains the leading cause of cancer death in Spain in both ...
Persones en situació de reclusió: Catalunya 2015-2018 (39/2020)
(2020-07)
In 2014, the Department of Health took care of the health care of people deprived of their liberty through the Catalan Institute of Health. The main principle of penitentiary health care is to ensure that the prison ...